Using a specific LSD1 inhibitor, CBB3001, it was found that in human colorectal carcinoma HCT116 cells, inhibition of LSD1 was sufficient to induce the proteolytic degradation of DNMT1 [108]. This evidence concerns the gene KDM1A and colorectal carcinoma.